烟草科技
煙草科技
연초과기
TOBACCO SCIENCE & TECHNOLOGY
2015年
1期
59-65
,共7页
王冰%赵阁%余晶晶%王昇%蔡君兰%于永杰%谢复炜
王冰%趙閣%餘晶晶%王昇%蔡君蘭%于永傑%謝複煒
왕빙%조각%여정정%왕승%채군란%우영걸%사복위
卷烟烟气%LC-MS/MS%丙烯酰胺%生物标志物%AAMA%GAMA%滤嘴分析法
捲煙煙氣%LC-MS/MS%丙烯酰胺%生物標誌物%AAMA%GAMA%濾嘴分析法
권연연기%LC-MS/MS%병희선알%생물표지물%AAMA%GAMA%려취분석법
Cigarette smoke%LC-MS/MS%Acrylamide%Biomarker%AAMA%GAMA%Filter analysis
为了准确评估吸烟过程中人体丙烯酰胺暴露量,建立了测定丙烯酰胺巯基尿酸(MA)代谢物N-乙酰基-S-(2-氨基甲酰乙基)-L-巯基丙氨酸(AAMA)、N-乙酰基-S-(2-氨基甲酰-2-羟基乙基)-L-巯基丙氨酸(GAMA)的固相萃取-高效液相色谱质谱联用(SPE-LC-MS/MS)方法,采用该方法对吸烟者和非吸烟者尿液中的AAMA和GAMA进行了测定,并将数据与采用滤嘴分析法得到的评价结果进行了相关分析。结果表明:①该方法准确灵敏,日内、日间精密度分别小于7%和11%,回收率94.9%~100.0%,AAMA和GAMA的检测限分别为0.6和0.1 ng/mL。②吸烟者尿液中AAMA和GAMA均值是非吸烟者的3倍左右。③尿液中丙烯酰胺主要代谢物AAMA的质量浓度与应用滤嘴分析法测得的烟气丙烯酰胺暴露量有一定相关性(R=0.567,P<0.03)。
為瞭準確評估吸煙過程中人體丙烯酰胺暴露量,建立瞭測定丙烯酰胺巰基尿痠(MA)代謝物N-乙酰基-S-(2-氨基甲酰乙基)-L-巰基丙氨痠(AAMA)、N-乙酰基-S-(2-氨基甲酰-2-羥基乙基)-L-巰基丙氨痠(GAMA)的固相萃取-高效液相色譜質譜聯用(SPE-LC-MS/MS)方法,採用該方法對吸煙者和非吸煙者尿液中的AAMA和GAMA進行瞭測定,併將數據與採用濾嘴分析法得到的評價結果進行瞭相關分析。結果錶明:①該方法準確靈敏,日內、日間精密度分彆小于7%和11%,迴收率94.9%~100.0%,AAMA和GAMA的檢測限分彆為0.6和0.1 ng/mL。②吸煙者尿液中AAMA和GAMA均值是非吸煙者的3倍左右。③尿液中丙烯酰胺主要代謝物AAMA的質量濃度與應用濾嘴分析法測得的煙氣丙烯酰胺暴露量有一定相關性(R=0.567,P<0.03)。
위료준학평고흡연과정중인체병희선알폭로량,건립료측정병희선알구기뇨산(MA)대사물N-을선기-S-(2-안기갑선을기)-L-구기병안산(AAMA)、N-을선기-S-(2-안기갑선-2-간기을기)-L-구기병안산(GAMA)적고상췌취-고효액상색보질보련용(SPE-LC-MS/MS)방법,채용해방법대흡연자화비흡연자뇨액중적AAMA화GAMA진행료측정,병장수거여채용려취분석법득도적평개결과진행료상관분석。결과표명:①해방법준학령민,일내、일간정밀도분별소우7%화11%,회수솔94.9%~100.0%,AAMA화GAMA적검측한분별위0.6화0.1 ng/mL。②흡연자뇨액중AAMA화GAMA균치시비흡연자적3배좌우。③뇨액중병희선알주요대사물AAMA적질량농도여응용려취분석법측득적연기병희선알폭로량유일정상관성(R=0.567,P<0.03)。
In order to assess the exposure to acrylamide of a smoker during smoking accurately, an SPE-HPLC-MS/MS method was developed for determining the mercapturic acid (MA) metabolites, N-acetyl-S-(2-carbamoylethyl)-L-cysteine (AAMA) and N-acetyl-S-(2-carbamoyl-2-hychoxyethyl)-L-cysteine(GAMA), of acrylamide in human urine.The contents of AAMA and GAMA in the urine of smokers and nonsmokers were determined, and the correlation analysis between the determined data and the acrylamide exposure evaluated by filter analysis was conducted. The results showed that: 1)The method was accurate and sensitive with the intra-day and inter-day precisions less than 7% and 11%, respectively. The recoveries ranged from 94.9%to 100.0%, and the detection limits of AAMA and GAMA were 0.6 and 0.1 ng/mL, respectively. 2) The mean value of AAMA and GAMA in smokers??urine was three times the value in nonsmokers’. 3) The content of AAMA, the main metabolite of acrylamide, in urine had a certain correlation(R=0.567, P<0.03)with the acrylamide exposure determined by filter analysis.